# q01 rev 1 - shortcut auditor (fresh shortcut-auditor, packet shortcut), 2026-10-06

Raw return as received:

answer: Flat. When the U.S. Consulting Services divestiture closed in April 2026, the guidance in force was the February 4, 2026 guidance. It projected fiscal 2026 adjusted operating income for "Other" to be flat, meaning about 0% growth on the fiscal 2025 base of $352M. "Other" is the non-reportable group of MWI Animal Health, Profarma, U.S. Consulting Services and certain parts of PharmaLex.

verdict: clear

shortest_path:
1. **Date and group (D05, Q3 FY2026 release, filed 2026-08-05), line 81:** "These businesses include MWI Animal Health, Profarma, U.S. Consulting Services (which was divested in April 2026), and certain components of PharmaLex." Line 95 also refers to "the April 2026 divestiture of U.S. Consulting Services". This makes the group "Other" and the closing month April 2026.
2. **Guidance in force (D01, Q1 FY2026 release, filed 2026-02-04):** this is the latest guidance in the packet issued before April 2026. In the adjusted operating income block, line 114 reads `|Other(2)|Flat|$352M|`. Line 103 explains the change: "improved results in Other as certain depreciable assets have been fully impaired as of December 31, 2025." I confirmed the same row in the original docs file at line 115.
3. **No change between February and the closing (D03, Q2 FY2026 release, filed 2026-05-06):**
   - Line 17 says EPS guidance was "raised from the previous range of $17.45 to $17.75". That is the range D01 reaffirmed, so D01's guidance was still current through April.
   - Line 112 says the update reflects "updated operating income expectations in Other as a result of MWI now being accounted for as 'held for sale'". The "Other" guidance therefore only changed on May 6, to "High-single digit growth".
4. No calculation is needed. "Flat" against $352M means about $352M, or 0%.

sufficient_documents:
- D05 plus D01 are the minimum: D05 gives the date and group, D01 gives the guidance in force.
- D03 confirms that D01 was still the current guidance through April.
- D06 (line 121) also shows that "Other" includes U.S. Consulting Services, but it doesn't give the closing date.
- No single document answers the whole question. The only release that dates the divestiture (D05) carries a later guidance figure. D01 and D03 don't mention the closing.

searches:
- **Terms:** consulting; divest/divestiture/sale of/completed the/closed the; April; held for sale; Covetrus; strategic alternatives; expected to close/definitive agreement/agreement to sell; the "Other" guidance rows; previous range/raised from/reaffirm/updating its outlook; "2026" in D02 and D04.
- **Read directly:** manifest; D01, D03, D05 and D06 from the headline through the guidance tables; D05 footnotes at lines 255–274.
- **Grep only:** D02 and D04 (FY2025 releases, no "2026" matches, so they're distractors).
- **Checked against the original docs files:** the key strings from D01, D03 and D05.
- I did not open question.txt or anything outside docs/ and text/. No contamination was seen.

readings/gaps:
- **Other answers a reader could give, all from the wrong time:**
  - "High-single digit growth" (D03, May 6, 2026): the first guidance after the closing, but issued after it, so it wasn't current at the time.
  - "~10% growth" (D05, August 2026): from the release that reports the divestiture, but it's a later guidance.
  - "1% to 4% decline" (D06, November 2025): the original FY2026 guidance, replaced on February 4, 2026.
- **Gaps:**
  - The exact closing day in April isn't given. Since any April date falls between February 4 and May 6, it doesn't affect the answer.
  - D05 says the previous EPS range was $17.70–$17.90, which differs from D03's $17.65–$17.90. So there was a guidance update between May 6 and August 5 that isn't in the packet. It comes after April and doesn't affect this answer, but it shows Cencora sometimes updates guidance between earnings releases.
  - The evidence that nothing changed between February 4 and May 6 rests on the EPS "previous range" link plus D03's wording about "Other". No document shows a business-group-level update in that window. Material outside the packet wasn't checked.
  - The bold formatting that marks updated figures in the guidance tables was lost in text extraction. It doesn't affect the answer.
  - The financial statement tables in D01, D03, D05 and D06 and the full text of D02 and D04 were not read line by line.

Paths:
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r1-v2-0c4ada79857fe6002f3e54c31fc4c9ba16909a3d678a0fee82bef0a049662c74\shortcut\text\D05.txt
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r1-v2-0c4ada79857fe6002f3e54c31fc4c9ba16909a3d678a0fee82bef0a049662c74\shortcut\text\D01.txt
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r1-v2-0c4ada79857fe6002f3e54c31fc4c9ba16909a3d678a0fee82bef0a049662c74\shortcut\text\D03.txt
- D:\Dev\Docket\tasks\aq-01322\runs\q01-r1-v2-0c4ada79857fe6002f3e54c31fc4c9ba16909a3d678a0fee82bef0a049662c74\shortcut\text\D06.txt
